Open AccessTacrolimus Combined with Corticosteroids Improved the Outcome of CIDP Patients with Autoantibodies Against Paranodal Proteins
Author(s) -
Mengjiao Yang,
Xu Li,
Suqiong Ji,
Huajie Gao,
Qing Zhang,
Bitao Bu
Publication year - 2022
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s361461
Subject(s) - tacrolimus , medicine , discontinuation , autoantibody , calcineurin , gastroenterology , regimen , immunology , antibody , transplantation
To investigate the response of tacrolimus to chronic inflammatory demyelinating polyneuropathy (CIDP) with autoantibodies against paranodal proteins, including neurofascin-155 (NF155), contactin-1 (CNTN1) and contactin-associated protein 1 (Caspr1).